Please use this identifier to cite or link to this item: https://essuir.sumdu.edu.ua/handle/123456789/84480
Or use following links to share this resource in social networks: Recommend this item
Title Levels of proinflammatory cytokines IL-17 and IL-23 in patients with alzheimer’s disease, mild cognitive impairment and vascular dementia
Authors Dubenko, O.E.
Chyniak, Olha Serhiivna  
Potapov, Oleksandr Oleksandrovych  
ORCID http://orcid.org/0000-0002-6008-1039
http://orcid.org/0000-0002-0913-3024
Keywords Alzheimer’s disease
vascular dementia
interleukins
Type Article
Date of Issue 2021
URI https://essuir.sumdu.edu.ua/handle/123456789/84480
Publisher Aluna Publishing
License Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International
Citation Dubenko OE, Chyniak OS, Potapov OO. Levels of proinflammatory cytokines IL-17 and IL-23 in patients with alzheimer’s disease, mild cognitive impairment and vascular dementia. Wiadomosci lekarskie. 2021;74(1):68-71. doi: 10.36740/WLek202101113.
Abstract To research differences of interleukin (IL)-17 and IL-23 serum levels in patients with Alzheimer’s disease, vascular dementia and mild cognitive impairment. Material and methods: Serum levels of IL-17 and IL-23 were measure by ELISA for 15 patients with Alzheimer’s disease, 14 with vascular dementia, 30 with mild cognitive impairment and 30 control individuals without cognitive impairment. Results: Serum concentrations of IL-17 were significantly higher in Alzheimer’s disease patients (P=0.0023) than control, in vascular dementia no significant differences (P=0.4154). Level of IL-23 was significantly higher than control in Alzheimer’s disease patients (P=0.0170) and vascular dementia (P=0.0002), but in Alzheimer’s disease it was in 12.5 time higher. In total mild cognitive impairment patients no significant differences in interleukin concentration with control, but significant differences observed for amnestic form in IL-17 (P=0.0436) and IL-23 (P=0.0019). Conclusions: IL-17 and IL-23 level significant higher in Alzheimer’s disease patients compared with control and vascular dementia. From mild cognitive impairment levels of detectable interleukins was higher in amnestic form that may be early marker of progression in Alzheimer’s disease.
Appears in Collections: Наукові видання (НН МІ)

Views

Australia Australia
1
Belgium Belgium
19554
Chile Chile
1
China China
349318993
Egypt Egypt
1
Germany Germany
1479
Greece Greece
192
Hong Kong SAR China Hong Kong SAR China
580261697
Iran Iran
1
Ireland Ireland
382076
Italy Italy
-1844322335
Japan Japan
1
Lithuania Lithuania
1
Singapore Singapore
-1844322329
Slovenia Slovenia
813769742
South Korea South Korea
183013179
Ukraine Ukraine
1557771923
United Kingdom United Kingdom
-1844322331
United States United States
813769741
Unknown Country Unknown Country
-9335739
Vietnam Vietnam
194

Downloads

Brazil Brazil
1
Chile Chile
1
China China
1
Finland Finland
1
Germany Germany
1
Iraq Iraq
1
Ireland Ireland
1
Italy Italy
1
Lithuania Lithuania
1
Singapore Singapore
1
Slovenia Slovenia
1
Ukraine Ukraine
349318990
United Kingdom United Kingdom
1
United States United States
813769739
Vietnam Vietnam
1

Files

File Size Format Downloads
Dubenko_Alzheimer’s_disease.pdf 332.17 kB Adobe PDF 1163088742

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.